Supply of Pharmaceutical products

Subject of this paper is to conclude discount agreements pursuant to [section] 130a para. 8 SGBV for drug combination levodopa / carbidopa / entacapone (ATC code N04BA03) under a so-called "open-house model." All interested and suitable pharmaceutical company will SGB V offered for drug co...

Celý popis

Uložené v:
Podrobná bibliografia
Vydané v:MENA Report
Médium: Newsletter
Jazyk:English
Vydavateľské údaje: Camden Disco Digital Media, Inc 21.11.2014
Predmet:
Agreements
Annual reports
Order quantity
Pharmaceutical industry
ISSN:2219-0112
On-line prístup:Získať plný text
Tagy: Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
Popis
Shrnutí:Subject of this paper is to conclude discount agreements pursuant to [section] 130a para. 8 SGBV for drug combination levodopa / carbidopa / entacapone (ATC code N04BA03) under a so-called "open-house model." All interested and suitable pharmaceutical company will SGB V offered for drug combination levodopa / carbidopa / entacapone default under uniform conditions, as well as a single access method of the financial statements to a rebate agreement pursuant to [section] 130a para. 8. An exclusivity is not given. The order quantity is unknown at the time the agreement and in particular on the demand of the insured, the evolution of the number of insured, from the prescribing behavior of physicians contract and the delivery and storage behaviourof community pharmacies dependent. The client does not guarantee any minimum purchase quantities.
ISSN:2219-0112